nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—SLC22A12—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A8—age related macular degeneration	0.0652	0.0652	CbGpPWpGaD
Losartan—SLC2A9—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.0324	0.0324	CbGpPWpGaD
Losartan—SLC22A12—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.0296	0.0296	CbGpPWpGaD
Losartan—SLC2A9—NRF2 pathway—SQSTM1—age related macular degeneration	0.0227	0.0227	CbGpPWpGaD
Losartan—SLC2A9—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.0185	0.0185	CbGpPWpGaD
Losartan—ALB—HDL-mediated lipid transport—CETP—age related macular degeneration	0.0184	0.0184	CbGpPWpGaD
Losartan—ABCB1—ABC-family proteins mediated transport—ABCG4—age related macular degeneration	0.0182	0.0182	CbGpPWpGaD
Losartan—CYP2C19—Melatonin metabolism and effects—MAP2—age related macular degeneration	0.0176	0.0176	CbGpPWpGaD
Losartan—SLC22A12—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.0169	0.0169	CbGpPWpGaD
Losartan—SLC2A9—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.0165	0.0165	CbGpPWpGaD
Losartan—SLC2A9—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.0165	0.0165	CbGpPWpGaD
Losartan—ABCB1—ABC-family proteins mediated transport—ABCA4—age related macular degeneration	0.0162	0.0162	CbGpPWpGaD
Losartan—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A8—age related macular degeneration	0.0161	0.0161	CbGpPWpGaD
Losartan—SLC22A12—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.015	0.015	CbGpPWpGaD
Losartan—SLC22A12—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.015	0.015	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—NMNAT1—age related macular degeneration	0.0144	0.0144	CbGpPWpGaD
Losartan—CYP1A2—Melatonin metabolism and effects—MAP2—age related macular degeneration	0.0137	0.0137	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—ELOVL4—age related macular degeneration	0.0126	0.0126	CbGpPWpGaD
Losartan—ACE—Metabolism of proteins—B3GLCT—age related macular degeneration	0.0122	0.0122	CbGpPWpGaD
Losartan—ACE—Metabolism of proteins—SKIV2L—age related macular degeneration	0.0122	0.0122	CbGpPWpGaD
Losartan—ALB—Platelet degranulation—SERPING1—age related macular degeneration	0.0121	0.0121	CbGpPWpGaD
Losartan—ALB—Response to elevated platelet cytosolic Ca2+—SERPING1—age related macular degeneration	0.0115	0.0115	CbGpPWpGaD
Losartan—ALB—Lipoprotein metabolism—LIPC—age related macular degeneration	0.011	0.011	CbGpPWpGaD
Losartan—ALB—Lipoprotein metabolism—CETP—age related macular degeneration	0.0106	0.0106	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—SLC16A8—age related macular degeneration	0.0102	0.0102	CbGpPWpGaD
Losartan—AGTR1—GPCRs, Class A Rhodopsin-like—RHO—age related macular degeneration	0.00993	0.00993	CbGpPWpGaD
Losartan—SLCO1B3—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.0099	0.0099	CbGpPWpGaD
Losartan—ALB—HDL-mediated lipid transport—APOE—age related macular degeneration	0.00975	0.00975	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—RHO—age related macular degeneration	0.00851	0.00851	CbGpPWpGaD
Losartan—AGTR1—Allograft Rejection—C3—age related macular degeneration	0.00828	0.00828	CbGpPWpGaD
Losartan—SLC2A9—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00813	0.00813	CbGpPWpGaD
Losartan—ACE—Metabolism of proteins—ADAMTS9—age related macular degeneration	0.00785	0.00785	CbGpPWpGaD
Losartan—SLC22A12—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00743	0.00743	CbGpPWpGaD
Losartan—UGT1A3—NRF2 pathway—SQSTM1—age related macular degeneration	0.00738	0.00738	CbGpPWpGaD
Losartan—SLC22A6—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.00731	0.00731	CbGpPWpGaD
Losartan—ALB—Lipid and lipoprotein metabolism—LIPC—age related macular degeneration	0.00728	0.00728	CbGpPWpGaD
Losartan—ALB—Lipid and lipoprotein metabolism—CETP—age related macular degeneration	0.00702	0.00702	CbGpPWpGaD
Losartan—SLCO1B1—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.00665	0.00665	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00657	0.00657	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—RHO—age related macular degeneration	0.00648	0.00648	CbGpPWpGaD
Losartan—UGT2B7—NRF2 pathway—SQSTM1—age related macular degeneration	0.00628	0.00628	CbGpPWpGaD
Losartan—SLCO1B3—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00565	0.00565	CbGpPWpGaD
Losartan—ALB—Lipoprotein metabolism—APOE—age related macular degeneration	0.0056	0.0056	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—SERPING1—age related macular degeneration	0.00537	0.00537	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—LIPC—age related macular degeneration	0.00521	0.00521	CbGpPWpGaD
Losartan—CYP2C19—Melatonin metabolism and effects—APOE—age related macular degeneration	0.00517	0.00517	CbGpPWpGaD
Losartan—UGT1A1—NRF2 pathway—SQSTM1—age related macular degeneration	0.0051	0.0051	CbGpPWpGaD
Losartan—SLCO1B3—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00503	0.00503	CbGpPWpGaD
Losartan—SLCO1B3—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00503	0.00503	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—CETP—age related macular degeneration	0.00502	0.00502	CbGpPWpGaD
Losartan—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—age related macular degeneration	0.00495	0.00495	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00441	0.00441	CbGpPWpGaD
Losartan—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—age related macular degeneration	0.00436	0.00436	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00417	0.00417	CbGpPWpGaD
Losartan—AGTR1—Allograft Rejection—VEGFA—age related macular degeneration	0.00416	0.00416	CbGpPWpGaD
Losartan—AGTR1—Peptide ligand-binding receptors—C3—age related macular degeneration	0.0041	0.0041	CbGpPWpGaD
Losartan—CYP1A2—Melatonin metabolism and effects—APOE—age related macular degeneration	0.00403	0.00403	CbGpPWpGaD
Losartan—ALB—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.0038	0.0038	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00379	0.00379	CbGpPWpGaD
Losartan—ALB—Vitamin B12 Metabolism—CRP—age related macular degeneration	0.00374	0.00374	CbGpPWpGaD
Losartan—ALB—Lipid and lipoprotein metabolism—APOE—age related macular degeneration	0.00372	0.00372	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00372	0.00372	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00372	0.00372	CbGpPWpGaD
Losartan—ALB—Vitamin B12 Metabolism—APOE—age related macular degeneration	0.00366	0.00366	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—RHO—age related macular degeneration	0.00366	0.00366	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—NMNAT1—age related macular degeneration	0.00355	0.00355	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00338	0.00338	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00338	0.00338	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—NMNAT1—age related macular degeneration	0.00335	0.00335	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—RHO—age related macular degeneration	0.00333	0.00333	CbGpPWpGaD
Losartan—AGTR1—Peptide ligand-binding receptors—CCL2—age related macular degeneration	0.00321	0.00321	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—RDH8—age related macular degeneration	0.00321	0.00321	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—CD36—age related macular degeneration	0.00315	0.00315	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—ELOVL4—age related macular degeneration	0.0031	0.0031	CbGpPWpGaD
Losartan—ALB—Vitamin B12 Metabolism—CCL2—age related macular degeneration	0.00308	0.00308	CbGpPWpGaD
Losartan—ALB—Folate Metabolism—CRP—age related macular degeneration	0.00305	0.00305	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—CD36—age related macular degeneration	0.00302	0.00302	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—NMNAT1—age related macular degeneration	0.00302	0.00302	CbGpPWpGaD
Losartan—ALB—Hemostasis—F13B—age related macular degeneration	0.00294	0.00294	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—ELOVL4—age related macular degeneration	0.00292	0.00292	CbGpPWpGaD
Losartan—ALB—Platelet degranulation—CD36—age related macular degeneration	0.0029	0.0029	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—RPE65—age related macular degeneration	0.0028	0.0028	CbGpPWpGaD
Losartan—ALB—Hemostasis—SERPING1—age related macular degeneration	0.00277	0.00277	CbGpPWpGaD
Losartan—ALB—Response to elevated platelet cytosolic Ca2+—CD36—age related macular degeneration	0.00276	0.00276	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00275	0.00275	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00271	0.00271	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—APOE—age related macular degeneration	0.00266	0.00266	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—ELOVL4—age related macular degeneration	0.00264	0.00264	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00261	0.00261	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00253	0.00253	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00252	0.00252	CbGpPWpGaD
Losartan—ALB—Folate Metabolism—CCL2—age related macular degeneration	0.00251	0.00251	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—SLC16A8—age related macular degeneration	0.0025	0.0025	CbGpPWpGaD
Losartan—SLCO1B3—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00249	0.00249	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—NMNAT1—age related macular degeneration	0.00245	0.00245	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—C3—age related macular degeneration	0.00243	0.00243	CbGpPWpGaD
Losartan—ALB—Selenium Micronutrient Network—CRP—age related macular degeneration	0.00242	0.00242	CbGpPWpGaD
Losartan—ALB—Hemostasis—RAD51B—age related macular degeneration	0.0024	0.0024	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—SLC16A8—age related macular degeneration	0.00236	0.00236	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.00232	0.00232	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00226	0.00226	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—ABCA4—age related macular degeneration	0.00226	0.00226	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—NMNAT1—age related macular degeneration	0.00225	0.00225	CbGpPWpGaD
Losartan—ALB—Hemostasis—SLC16A8—age related macular degeneration	0.00223	0.00223	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00217	0.00217	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00215	0.00215	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—ELOVL4—age related macular degeneration	0.00214	0.00214	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—SLC16A8—age related macular degeneration	0.00213	0.00213	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—C3—age related macular degeneration	0.0021	0.0021	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.00208	0.00208	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00206	0.00206	CbGpPWpGaD
Losartan—ALB—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.00199	0.00199	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—RHO—age related macular degeneration	0.00196	0.00196	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—ELOVL4—age related macular degeneration	0.00196	0.00196	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00193	0.00193	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00193	0.00193	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.0019	0.0019	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00184	0.00184	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00182	0.00182	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00176	0.00176	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00176	0.00176	CbGpPWpGaD
Losartan—ACE—Metabolism of proteins—CCL2—age related macular degeneration	0.00173	0.00173	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—SLC16A8—age related macular degeneration	0.00173	0.00173	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00169	0.00169	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00169	0.00169	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00167	0.00167	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—CCL2—age related macular degeneration	0.00164	0.00164	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—SLC16A8—age related macular degeneration	0.00158	0.00158	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00157	0.00157	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.0015	0.0015	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—NMNAT1—age related macular degeneration	0.00149	0.00149	CbGpPWpGaD
Losartan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—age related macular degeneration	0.00141	0.00141	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00139	0.00139	CbGpPWpGaD
Losartan—ALB—Platelet degranulation—VEGFA—age related macular degeneration	0.00138	0.00138	CbGpPWpGaD
Losartan—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—age related macular degeneration	0.00131	0.00131	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—ELOVL4—age related macular degeneration	0.0013	0.0013	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—NMNAT1—age related macular degeneration	0.00129	0.00129	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—CD36—age related macular degeneration	0.00129	0.00129	CbGpPWpGaD
Losartan—ALB—Metabolism—NMNAT1—age related macular degeneration	0.00128	0.00128	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—LIPC—age related macular degeneration	0.00128	0.00128	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—CETP—age related macular degeneration	0.00124	0.00124	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—VEGFA—age related macular degeneration	0.00122	0.00122	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—LIPC—age related macular degeneration	0.00121	0.00121	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—C3—age related macular degeneration	0.00118	0.00118	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—CETP—age related macular degeneration	0.00116	0.00116	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—NMNAT1—age related macular degeneration	0.00115	0.00115	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ELOVL4—age related macular degeneration	0.00113	0.00113	CbGpPWpGaD
Losartan—ABCB1—Metabolism—NMNAT1—age related macular degeneration	0.00113	0.00113	CbGpPWpGaD
Losartan—ALB—Metabolism—ELOVL4—age related macular degeneration	0.00112	0.00112	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TGFBR1—age related macular degeneration	0.0011	0.0011	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—LIPC—age related macular degeneration	0.00109	0.00109	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—C3—age related macular degeneration	0.00108	0.00108	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00106	0.00106	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—NMNAT1—age related macular degeneration	0.00105	0.00105	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—SLC16A8—age related macular degeneration	0.00105	0.00105	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—CETP—age related macular degeneration	0.00105	0.00105	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00105	0.00105	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00104	0.00104	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00101	0.00101	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ELOVL4—age related macular degeneration	0.00101	0.00101	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.001	0.001	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—SQSTM1—age related macular degeneration	0.001	0.001	CbGpPWpGaD
Losartan—ABCB1—Metabolism—ELOVL4—age related macular degeneration	0.000983	0.000983	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000954	0.000954	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000934	0.000934	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000931	0.000931	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ELOVL4—age related macular degeneration	0.000919	0.000919	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—SLC16A8—age related macular degeneration	0.00091	0.00091	CbGpPWpGaD
Losartan—ALB—Metabolism—SLC16A8—age related macular degeneration	0.000905	0.000905	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000901	0.000901	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—NMNAT1—age related macular degeneration	0.000898	0.000898	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—LIPC—age related macular degeneration	0.000885	0.000885	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—CETP—age related macular degeneration	0.000853	0.000853	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000851	0.000851	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—CCL2—age related macular degeneration	0.000842	0.000842	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000836	0.000836	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000821	0.000821	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—SLC16A8—age related macular degeneration	0.000812	0.000812	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—LIPC—age related macular degeneration	0.000811	0.000811	CbGpPWpGaD
Losartan—ABCB1—Metabolism—SLC16A8—age related macular degeneration	0.000793	0.000793	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ELOVL4—age related macular degeneration	0.000785	0.000785	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—CETP—age related macular degeneration	0.000782	0.000782	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—CD36—age related macular degeneration	0.000742	0.000742	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—SLC16A8—age related macular degeneration	0.000741	0.000741	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000727	0.000727	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000702	0.000702	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—CD36—age related macular degeneration	0.0007	0.0007	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—NMNAT1—age related macular degeneration	0.000693	0.000693	CbGpPWpGaD
Losartan—ALB—Hemostasis—CD36—age related macular degeneration	0.000662	0.000662	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—APOE—age related macular degeneration	0.000655	0.000655	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—C3—age related macular degeneration	0.000635	0.000635	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—SLC16A8—age related macular degeneration	0.000633	0.000633	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—CD36—age related macular degeneration	0.000631	0.000631	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—APOE—age related macular degeneration	0.000617	0.000617	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.000612	0.000612	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000606	0.000606	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	0.000606	0.000606	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000603	0.000603	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000602	0.000602	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—APOE—age related macular degeneration	0.000591	0.000591	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—KDR—age related macular degeneration	0.000579	0.000579	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—APOE—age related macular degeneration	0.000557	0.000557	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000541	0.000541	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—LIPC—age related macular degeneration	0.000538	0.000538	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000535	0.000535	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000532	0.000532	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CETP—age related macular degeneration	0.000519	0.000519	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—CD36—age related macular degeneration	0.000513	0.000513	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CCL2—age related macular degeneration	0.000497	0.000497	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000494	0.000494	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	0.000488	0.000488	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000478	0.000478	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—CD36—age related macular degeneration	0.00047	0.00047	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—LIPC—age related macular degeneration	0.000466	0.000466	CbGpPWpGaD
Losartan—ALB—Metabolism—LIPC—age related macular degeneration	0.000463	0.000463	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—APOE—age related macular degeneration	0.000453	0.000453	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CETP—age related macular degeneration	0.000449	0.000449	CbGpPWpGaD
Losartan—ALB—Metabolism—CETP—age related macular degeneration	0.000447	0.000447	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000435	0.000435	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000422	0.000422	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—LIPC—age related macular degeneration	0.000416	0.000416	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—APOE—age related macular degeneration	0.000415	0.000415	CbGpPWpGaD
Losartan—ABCB1—Metabolism—LIPC—age related macular degeneration	0.000406	0.000406	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CETP—age related macular degeneration	0.000401	0.000401	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CETP—age related macular degeneration	0.000392	0.000392	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—LIPC—age related macular degeneration	0.000379	0.000379	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000372	0.000372	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CETP—age related macular degeneration	0.000366	0.000366	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—LIPC—age related macular degeneration	0.000324	0.000324	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—VEGFA—age related macular degeneration	0.000319	0.000319	CbGpPWpGaD
Losartan—ALB—Hemostasis—VEGFA—age related macular degeneration	0.000315	0.000315	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CETP—age related macular degeneration	0.000313	0.000313	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CD36—age related macular degeneration	0.000312	0.000312	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—APOE—age related macular degeneration	0.000275	0.000275	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CD36—age related macular degeneration	0.00027	0.00027	CbGpPWpGaD
Losartan—ALB—Metabolism—CD36—age related macular degeneration	0.000269	0.000269	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—LIPC—age related macular degeneration	0.00025	0.00025	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CETP—age related macular degeneration	0.000241	0.000241	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CD36—age related macular degeneration	0.000241	0.000241	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—APOE—age related macular degeneration	0.000238	0.000238	CbGpPWpGaD
Losartan—ALB—Metabolism—APOE—age related macular degeneration	0.000237	0.000237	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CD36—age related macular degeneration	0.000235	0.000235	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CD36—age related macular degeneration	0.00022	0.00022	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—APOE—age related macular degeneration	0.000213	0.000213	CbGpPWpGaD
Losartan—ABCB1—Metabolism—APOE—age related macular degeneration	0.000208	0.000208	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—APOE—age related macular degeneration	0.000194	0.000194	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CD36—age related macular degeneration	0.000188	0.000188	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—APOE—age related macular degeneration	0.000166	0.000166	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CD36—age related macular degeneration	0.000145	0.000145	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—APOE—age related macular degeneration	0.000128	0.000128	CbGpPWpGaD
